Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: AI122390
NIAID NIH HHS
Grant: T32 AI074492
NIH HHS
Grant: DA046100
NIAID NIH HHS
Grant: UM1 AI148574
NIH HHS
Grant: AI120898
FWCI
4.72
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study
Additional file 1 of SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study
Additional file 1 of Community transmission of SARS-CoV-2 during the Delta wave in New York City
Additional file 1 of Community transmission of SARS-CoV-2 during the Delta wave in New York City